跳至主要内容
临床试验/ACTRN12614000193673
ACTRN12614000193673已完成不适用

In Patients with Cirrhosis Who Have Minimal Hepatic Encephalopathy, Is Chinese Herbal Medicine Formula Jieduhuayu Granules Effective in Improving Cognitive and Neurophysiological Functions?

ational Natural Science Foundation of China0 个研究点目标入组 80 人开始时间: 2014年2月24日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. All patients diagnosed as having cirrhosis at the Department of Hepatology of the First Affiliated Hospital of Guangxi University of Chinese Medicine, were candidates for enrollment.
  • 2. Patients’ Child-Turcotte-Pugh (CTP) class were A or B.
  • 3. Two or more positive indicators of NCT-A, the DST, the MMSE and the event related potential P300.

排除标准

  • 1. Overt HE or a history of overt HE;
  • 2. Patients’ Child-Turcotte-Pugh (CTP) class were C;
  • 3. Psychological or neurological disorders;
  • 4. History of recent (4 weeks) use of Tranquilizers or central nervous system depressants like psychotropic drugs or antiepileptics;
  • 5. History of recent (4 weeks) alcohol intake;
  • 6. Gastrointestinal bleeding, infection, or recent (2 weeks) use of antibiotics;
  • 7. Electrolyte imbalance due to the recent use (2weeks) of diuretics;
  • 8. Body temperature at 37.5 degrees celsius or higher;
  • 9. A history of shunt surgery or transjugular intrahepatic portosystemic shunt(TIPS) for portal hypertension;
  • 10. Renal impairment;
  • 11. Hepatocellular carcinoma;
  • 12. Severe diseases such as congestive heart failure, pulmonary disease;
  • 13. Inability to perform NCT-A tests and MMSE tests because of hearing impairs and/or poor vision.
  • 14. Illiterate or uncooperative patients.

研究者

发起方
ational Natural Science Foundation of China

相似试验